ELS vs REGN · P/E 32, rev $1.53B vs P/E 14, rev $14.34B
Equity Lifestyle Properties Inc (ELS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Equity Lifestyle Properties Inc (ELS) is a reit - residential company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ELS revenue for 2024-12-31 was $1.53B. Net income was $384.8M. Revenue was up 2.5% from 2023-12-31 to 2024-12-31. ELS currently screens at market cap $12.37B and trailing P/E 31.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ELS currently screens at market cap $12.37B and trailing P/E 31.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ELS and REGN stock pages for the full models.
Not investment advice.